NIH-funded research R01 grant

Improving cancer treatment strategies through advanced decision-making methods

Official title: Next-generation SMARTs for Discovery and Evaluation of Sequential Cancer Therapeutic Strategies

Funded at Duke University · NIH-10999444 · Data updated 2026-11-12

This study is looking at new ways to help doctors choose the best cancer treatments for patients by adjusting therapies based on how each person responds, while also providing support to manage side effects and improve overall well-being.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startDecember 11, 2023
Project endNovember 30, 2028
Funding year2025
Award (this year)$354,690
NIH project number5R01CA280970-02
Project IDNIH-10999444 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with cancer who are undergoing treatment and may benefit from tailored therapeutic strategies.

Less likely to help

Patients with non-cancerous conditions or those who are not currently receiving cancer treatment may not benefit from this research.

What this research studies

This research focuses on enhancing cancer treatment by developing innovative decision-making strategies that guide clinicians in selecting the most effective therapies for patients. It utilizes a method called Sequential Multiple Assignment Randomized Trials (SMARTs), which allows for real-time adjustments in treatment based on individual patient responses and evolving information. By analyzing various treatment options and their sequences, the goal is to optimize long-term benefits for patients undergoing cancer therapy. This approach also includes supportive behavioral interventions to help manage side effects and improve overall patient well-being.

Why it matters

Potential benefit: If successful, this research could lead to more personalized and effective cancer treatment plans that significantly improve patient outcomes.

How similar studies have gone: Previous research using SMARTs in cancer treatment has shown promising results, indicating that this approach is both innovative and grounded in successful methodologies.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Laber, Eric Benjamin — Duke University
  • Study coordinator: Laber, Eric Benjamin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.